PREMIUM
AIM IHT
AIM’s world leaders are poised
We pick through the latest results from two of AIM’s world leaders. The shares of both have struggled to advance over recent years but, with plenty of investment of late and valuations compelling, they look well-placed to deliver. (Premium)
Client portfolios managed by our associates, Fundamental Asset Management, may hold shares in companies covered below
Advanced Medical: will it start to deliver?
Advanced Medical Solutions (AIM: AMS), a world-leading specialist in tissue-healing technologies, announced results for the year ended 31 December 2023.
AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices , bone substitutes and internal sealants, which it markets under its brands…
Continue reading our content…
Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
- Unlimited access to our market-beating portfolios
- In-depth coverage of many of the world’s great companies
- Unique insights from our top research team
Register FREE for access to limited content.
- Company and markets insights
- Sponsored content
- Podcasts
Previous article Next article
